Centre Hospitalier Regional Universitaire de Brest - Hopital Morvan

Brest 29200

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Extensive-Stage Small-Cell Lung Cancer, Prurigo Nodularis, Small-Cell Lung Cancer

Studies at this site

• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling